Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report elaborates on the current development of the Imatinib Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Mylan Pharms Inc
Sanofi SA
Dr Reddy's Laboratories
Sun Pharmaceuticals
Actavis Generics
Teva Pharmaceutical Industries Ltd
Apotex Inc
Glenmark Pharmaceuticals Ltd
Novartis
Cipla Inc
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Tablets
Capsules
Application:
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Imatinib Drug Industry Overview
-
1.1.1 Imatinib Drug Market Scope and Market Segments
-
1.1.2 Imatinib Drug Industry Characteristics
-
1.1.3 Global and China Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Imatinib Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Imatinib Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Tablets
-
1.2.2 Capsules
-
1.3 Global Imatinib Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Chronic Myelogenous Leukemia
-
1.3.2 Gastrointestinal Stromal Tumors
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Imatinib Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Imatinib Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Imatinib Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Imatinib Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Imatinib Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Imatinib Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Imatinib Drug Industry PEST Analysis
-
2.3 Imatinib Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Imatinib Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Imatinib Drug Industry
Chapter 3 Global and China Imatinib Drug Market, by Manufacturer
-
3.1 Global and China Imatinib Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Imatinib Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Imatinib Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Imatinib Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Imatinib Drug Market Top 3 Players
Chapter 4 Global and China Imatinib Drug Market, by Type (2017-2028)
-
4.1 Imatinib Drug Market Trend, by Type
-
4.2 Global Imatinib Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Imatinib Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Imatinib Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Imatinib Drug Price Trend, by Type (2017-2028)
-
4.3 China Imatinib Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Imatinib Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Imatinib Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Imatinib Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Imatinib Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Imatinib Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Imatinib Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Imatinib Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Imatinib Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Imatinib Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Imatinib Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Imatinib Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Imatinib Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Imatinib Drug Market Analysis
-
7.1 North America Imatinib Drug Market, by Type
-
7.2 North America Imatinib Drug Market, by Application
-
7.3 North America Imatinib Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Imatinib Drug Market Analysis
-
8.1 Europe Imatinib Drug Market, by Type
-
8.2 Europe Imatinib Drug Market, by Application
-
8.3 Europe Imatinib Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Imatinib Drug Market Analysis
-
9.1 APAC Imatinib Drug Market, by Type
-
9.2 APAC Imatinib Drug Market, by Application
-
9.3 APAC Imatinib Drug Market Analysis and Forecast, by Country
-
9.3.1 China Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Imatinib Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Imatinib Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Imatinib Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Imatinib Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Imatinib Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Imatinib Drug Company Profiles
-
11.1 Mylan Pharms Inc
-
11.1.1 Mylan Pharms Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Mylan Pharms Inc Imatinib Drug Product Profiles, Application and Specification
-
11.1.3 Mylan Pharms Inc Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sanofi SA
-
11.2.1 Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sanofi SA Imatinib Drug Product Profiles, Application and Specification
-
11.2.3 Sanofi SA Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Dr Reddy's Laboratories
-
11.3.1 Dr Reddy's Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Dr Reddy's Laboratories Imatinib Drug Product Profiles, Application and Specification
-
11.3.3 Dr Reddy's Laboratories Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Sun Pharmaceuticals
-
11.4.1 Sun Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Sun Pharmaceuticals Imatinib Drug Product Profiles, Application and Specification
-
11.4.3 Sun Pharmaceuticals Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Actavis Generics
-
11.5.1 Actavis Generics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Actavis Generics Imatinib Drug Product Profiles, Application and Specification
-
11.5.3 Actavis Generics Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Teva Pharmaceutical Industries Ltd
-
11.6.1 Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Teva Pharmaceutical Industries Ltd Imatinib Drug Product Profiles, Application and Specification
-
11.6.3 Teva Pharmaceutical Industries Ltd Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Apotex Inc
-
11.7.1 Apotex Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Apotex Inc Imatinib Drug Product Profiles, Application and Specification
-
11.7.3 Apotex Inc Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Glenmark Pharmaceuticals Ltd
-
11.8.1 Glenmark Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Glenmark Pharmaceuticals Ltd Imatinib Drug Product Profiles, Application and Specification
-
11.8.3 Glenmark Pharmaceuticals Ltd Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Novartis
-
11.9.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Novartis Imatinib Drug Product Profiles, Application and Specification
-
11.9.3 Novartis Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Cipla Inc
-
11.10.1 Cipla Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Cipla Inc Imatinib Drug Product Profiles, Application and Specification
-
11.10.3 Cipla Inc Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Imatinib Drug Industry Investment Prospect and Risk Assessment
-
12.1 Imatinib Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Imatinib Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Imatinib Drug Production Value and Growth Rate (2017-2028)
-
Figure China Imatinib Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Imatinib Drug Market Size and Growth Rate of Tablets (2017-2028)
-
Figure Global Imatinib Drug Market Size and Growth Rate of Capsules (2017-2028)
-
Figure Global Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia (2017-2028)
-
Figure Global Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors (2017-2028)
-
Figure Global Imatinib Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Imatinib Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Imatinib Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Imatinib Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Imatinib Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Imatinib Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Imatinib Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Imatinib Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Imatinib Drug Market Share, by Manufacturer in 2022
-
Table Global Imatinib Drug Sales Volume, by Type (2017-2028)
-
Table Global Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Imatinib Drug Sales Value, by Type (2017-2028)
-
Table Global Imatinib Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Imatinib Drug Price Trend, by Type (2017-2028)
-
Table China Imatinib Drug Sales Volume, by Type (2017-2028)
-
Table China Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Table China Imatinib Drug Sales Value, by Type (2017-2028)
-
Table China Imatinib Drug Sales Value Share, by Type (2017-2028)
-
Figure China Imatinib Drug Price Trend, by Type (2017-2028)
-
Table Global Imatinib Drug Sales Volume, by Application (2017-2028)
-
Table Global Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Imatinib Drug Sales Value, by Application (2017-2028)
-
Table Global Imatinib Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Imatinib Drug Sales Value Share, by Application (2017-2028)
-
Table China Imatinib Drug Sales Volume, by Application (2017-2028)
-
Table China Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Table China Imatinib Drug Sales Value, by Application (2017-2028)
-
Table China Imatinib Drug Sales Value Share, by Application (2017-2028)
-
Figure China Imatinib Drug Sales Value Share, by Application (2017-2028)
-
Figure China Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Imatinib Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Imatinib Drug Sales Volume, by Type (2017-2028)
-
Table North America Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Imatinib Drug Sales Volume, by Application (2017-2028)
-
Table North America Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Imatinib Drug Sales Volume, by Type (2017-2028)
-
Table Europe Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Imatinib Drug Sales Volume, by Application (2017-2028)
-
Table Europe Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Imatinib Drug Sales Volume, by Type (2017-2028)
-
Table APAC Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Imatinib Drug Sales Volume, by Application (2017-2028)
-
Table APAC Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Imatinib Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Imatinib Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Imatinib Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Imatinib Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Imatinib Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Imatinib Drug Sales Value and Growth Rate (2017-2028)
-
Table Mylan Pharms Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mylan Pharms Inc Product Profiles, Application and Specification
-
Table Mylan Pharms Inc Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi SA Product Profiles, Application and Specification
-
Table Sanofi SA Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dr Reddy's Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dr Reddy's Laboratories Product Profiles, Application and Specification
-
Table Dr Reddy's Laboratories Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sun Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sun Pharmaceuticals Product Profiles, Application and Specification
-
Table Sun Pharmaceuticals Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Actavis Generics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Actavis Generics Product Profiles, Application and Specification
-
Table Actavis Generics Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceutical Industries Ltd Product Profiles, Application and Specification
-
Table Teva Pharmaceutical Industries Ltd Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Apotex Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Apotex Inc Product Profiles, Application and Specification
-
Table Apotex Inc Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Glenmark Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Glenmark Pharmaceuticals Ltd Product Profiles, Application and Specification
-
Table Glenmark Pharmaceuticals Ltd Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cipla Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cipla Inc Product Profiles, Application and Specification
-
Table Cipla Inc Imatinib Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
